Cargando…
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder
CDKL5 Deficiency Disorder (CDD) is a rare, X-linked dominant condition that causes a developmental and epileptic encephalopathy (DEE). The incidence is between ~ 1:40,000 and 1:60,000 live births. Pathogenic variants in CDKL5 lead to seizures from infancy and severe neurodevelopmental delay. During...
Autores principales: | Amin, Sam, Monaghan, Marie, Aledo-Serrano, Angel, Bahi-Buisson, Nadia, Chin, Richard F., Clarke, Angus J., Cross, J. Helen, Demarest, Scott, Devinsky, Orrin, Downs, Jenny, Pestana Knight, Elia M., Olson, Heather, Partridge, Carol-Anne, Stuart, Graham, Trivisano, Marina, Zuberi, Sameer, Benke, Tim A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251467/ https://www.ncbi.nlm.nih.gov/pubmed/35795799 http://dx.doi.org/10.3389/fneur.2022.874695 |
Ejemplares similares
-
Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder
por: Wong, Kingsley, et al.
Publicado: (2022) -
Correction to: Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder
por: Wong, Kingsley, et al.
Publicado: (2022) -
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
por: Olson, Heather E., et al.
Publicado: (2021) -
Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021) -
Ataluren for drug‐resistant epilepsy in nonsense variant‐mediated Dravet syndrome and CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)